Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Andekærgaard Biogas ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   0.3% 0.3% 0.3% 0.3% 0.3% 0.3% 0.3% 0.3%   Bankruptcy risk   3.6% 3.3% 1.5% 1.5% 1.3% 1.6% 7.7% 7.7%   Credit score (0-100)   54 54 75 75 78 75 32 32   Credit rating   BBB BBB A A A A BB BB   Credit limit (kDKK)   -0.0 0.0 84.3 176.2 490.5 148.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -392 5,966 21,305 43,897 33,826 48,562 0.0 0.0   EBITDA   -452 4,622 19,923 41,811 31,677 40,033 0.0 0.0   EBIT   -452 650 15,558 37,316 26,905 33,624 0.0 0.0   Pre-tax profit (PTP)   -622.3 -241.0 14,639.8 36,768.5 25,869.7 31,854.3 0.0 0.0   Net earnings   -485.4 -187.9 11,419.0 28,679.4 20,179.9 24,846.4 0.0 0.0   Pre-tax profit without non-rec. items   -622 -241 14,640 36,768 25,870 31,854 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   38,200 58,217 56,460 55,368 68,784 66,329 0.0 0.0   Shareholders equity total   -480 -668 10,751 39,430 29,610 34,456 10,406 10,406   Interest-bearing liabilities   39,303 43,198 38,356 15,562 30,208 23,937 0.0 0.0   Balance sheet total (assets)   40,924 65,979 76,601 93,174 93,225 88,861 10,406 10,406   Net Debt   39,303 43,198 38,356 15,562 30,208 23,937 -10,406 -10,406     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -392 5,966 21,305 43,897 33,826 48,562 0.0 0.0   Gross profit growth   -2,006.2% 0.0% 257.1% 106.0% -22.9% 43.6% -100.0% 0.0%   Employees   1 2 3 3 3 4 0 0   Employee growth %   0.0% 100.0% 50.0% 0.0% 0.0% 33.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   40,924 65,979 76,601 93,174 93,225 88,861 10,406 10,406   Balance sheet change%   1,361.8% 61.2% 16.1% 21.6% 0.1% -4.7% -88.3% 0.0%   Added value   -452.0 4,621.5 19,923.2 41,810.9 31,400.5 40,033.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   35,702 16,045 -6,123 -5,587 8,644 -8,864 -66,329 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   115.4% 10.9% 73.0% 85.0% 79.5% 69.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -2.0% 1.2% 21.7% 44.0% 29.0% 36.9% 0.0% 0.0%   ROI %   -2.2% 1.6% 32.7% 67.8% 44.3% 53.7% 0.0% 0.0%   ROE %   -2.4% -0.4% 29.8% 114.3% 58.5% 77.6% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   -1.2% -1.0% 14.0% 42.3% 31.8% 38.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -8,696.0% 934.7% 192.5% 37.2% 95.4% 59.8% 0.0% 0.0%   Gearing %   -8,182.8% -6,464.8% 356.8% 39.5% 102.0% 69.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.8% 2.2% 2.3% 2.0% 5.0% 6.6% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   0.1 0.2 0.6 1.4 0.4 0.4 0.0 0.0   Current Ratio   0.1 0.2 0.6 1.6 0.6 0.7 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -38,680.4 -23,436.1 -11,973.6 13,632.7 -13,282.8 -11,210.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -452 2,311 6,641 13,937 10,467 10,008 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -452 2,311 6,641 13,937 10,559 10,008 0 0   EBIT / employee   -452 325 5,186 12,439 8,968 8,406 0 0   Net earnings / employee   -485 -94 3,806 9,560 6,727 6,212 0 0